
Yale Technologies
Yale Ventures oversees Yale's technology transfer office, protecting and licensing the intellectual property developed at Yale, and helping to bring breakthroughs to market as products and services that can make a difference in the world.
Yale Technologies Available for Licensing
Yale Principal Investigator Pitches and Presentations
Search (Pitches)
Search (Pitches)
-
Evershield: Long-acting, biodegradable implants for local, sustained drug release
W. Mark Saltzman, Ph.D. -
B3 Therapeutics: Bypassing the blood brain barrier for the treatment of primary CNS tumors and brain metastases
Ranjit S. Bindra, M.D., Ph.D. -
Brain Endothelium-Targeted Therapy for Cerebral Cavernous Malformations
Jaime Grutzendler, MD -
DNA Self-Activating Warheads (SAWs)
Seth Herzon, PhD -
Targeting Non-Tuberculous Mycobacteria with AI-Designed Antimicrobial Peptides
Jose Gomez-Villalobos, MD, MS -
EDDIT: Early Drug Discovery for Targeted Protein Degradation
Ho-Joon Lee, PhD -
ChondroNEXT will prevent progression of Osteoarthritis by preventing joint degeneration.
Stephen Waxman, MD, PhD -
Novel treatment for hypertrophic and keloidal scarring
Christopher G Bunick, MD/PhD -
A new class of selective GSK3B-inhibitors for refractory lymphoid malignancies
Markus Müschen, MD, PhD -
Harnessing p53beta as a medical treatment of skin cancer
Christine Ko, MD